Israeli pharma giant Teva lays off 250 of its Israel-based staff

Haaretz

Israeli pharma giant Teva lays off 250 of its Israel-based staff

The layoffs are carried out as part of a reorganization of the global division's operations, which employs 4,000 employees, 650 of whom are in Israel ■ The division was put up for sale in January 2024 at a value of $1.5 billion – efforts to sell it have so far failed

Go to News Site

Google Play

App Store